Welcome to our dedicated page for ACME UNITED SEC filings (Ticker: ACU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Acme United Corporation filings document the formal disclosures of an operating company that supplies first aid and medical products, safety solutions and cutting technology. Its 8-K reports include operating and financial results, material-event disclosures, acquisition-related reporting, credit-facility matters and other corporate updates affecting the company's capital and operating structure.
ACU proxy and annual-meeting filings cover board elections, executive compensation votes, equity incentive plan amendments and auditor ratification. The company's regulatory record also includes material agreement disclosures, including amendments to its secured revolving credit facility, along with governance matters and shareholder voting results.
Brian Olschan filed a Form 144 indicating an intention to sell 10,909 shares of ACME United Corp common stock through Fidelity Brokerage Services LLC on the AMEX, with an aggregate market value of $620,285.74. The disclosure notes that ACME United Corp had 3,810,359 shares outstanding. The shares to be sold were received as a stock award from the issuer on 07/24/2026 as compensation. The notice also lists sales during the past three months: 1,578 shares sold for $66,241.68 on 05/27/2026 and 3,255 shares sold for $136,707.51 on 05/28/2026.
ACME UNITED CORP director, Chairman and CEO Walter C. Johnsen reported several equity compensation transactions on 2026-07-29. He exercised 30,000 Employee Stock Options at $23.99 per share, receiving 30,000 shares of common stock, with 20,361 shares withheld to satisfy exercise price and/or tax obligations via net share settlement. He also received a grant of 25,000 new Employee Stock Options with an exercise price of $59.90 per share, exercisable beginning 2030-07-31 and expiring 2036-07-31.
ACME United Corp director Davidson Rex Lynn received a grant of 2,500 Employee Stock Options on July 29, 2026, each with an exercise price of $59.90 per share, exercisable into 2,500 shares of common stock and expiring July 29, 2036. Following this grant, he holds 31,500 stock options directly.
ACME United Corp director Paul J. Conway reported a grant of 2,500 Employee Stock Options dated 2026-07-29. The options have an exercise price of $59.90 per share, are exercisable starting 2026-07-30, and expire on 2036-07-29. After this award, he holds 10,000 options directly.
ACME United Corp director Brian Barker reported a grant of employee stock options on 2026-07-29. He received options to acquire 2,500 shares of common stock at an exercise price of $59.90 per share, exercisable from 2026-07-30 and expiring 2036-07-29, bringing his total option holdings to 21,500 derivative securities.
ACME United Corp director Susan H Murphy reported a grant of 2,500 Employee Stock Options on 2026-07-29. Each option is exercisable for Common Stock at an exercise price of $59.90 per share, exercisable starting 2026-07-30 and expiring on 2036-07-29. Following this award, she holds 31,500 options in total as derivative securities, reflecting a compensation-related acquisition rather than an open-market purchase.
ACME UNITED CORP director Holden Richmond Y Jr reported a grant/award of employee stock options covering 2,500 shares of common stock on 2026-07-29. The options have a $59.90 per share exercise price, are exercisable starting 2026-07-30, expire on 2036-07-29, and bring his directly held option awards to 15,600 derivative securities.
Acme United Corp. Chief Financial Officer Paul G. Driscoll exercised 15,000 employee stock options at $24.92 on July 29, 2026, acquiring 15,000 common shares. He also received a new grant of 15,000 options at an exercise price of $59.90 expiring in 2036, and 10,300 shares were withheld to cover obligations through net share settlement.
ACME United Corp reported that director and President/COO Brian S. Olsch an received a grant of employee stock options for 20,000 underlying shares of common stock on July 29, 2026. The options have an exercise price of $59.90 per share, an exercise date of July 30, 2026, and an expiration date of July 29, 2036. Following this award, he directly holds 226,700 derivative securities.
Acme United Corp President and COO Brian S. Olschan exercised 35,000 employee stock options on July 24, 2026 at $22.66 per share, receiving an equal number of common shares. To effect a net share settlement, 24,091 shares of common stock were withheld at $53.94 per share to cover the exercise price or tax obligations. Following the transaction, he directly holds 206,700 employee stock options.